ATR and type 1 diabetes mellitus: While the ATR blockade through candesartan could only elicit DR prevention in type 1 and disease regression in type 2 diabetes (most effective in the early stages of DR), the development of microaneurysms was hindered in both diabetes type 1 and 2 (Sjølie et al., 2011).